Literature DB >> 20179794

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.

Jennifer H Martin1, Ross Norris, Michael Barras, Jason Roberts, Ray Morris, Matthew Doogue, Graham R D Jones.   

Abstract

The Review is a welcome and up-to-date consensus statement on the use of vancomycin. Although many of the points are pertinent to Australasian practice, the clinical context may be subtly different such that different recommendations apply here. It is thus an apt time for clinical, biochemical, pharmacological and pathology staff in Australasia to collaborate and discuss the literature with particular relevance to establishing guidelines for an Australasian context. The new TG (Version 14) will be an interesting update in the antibiotic TDM area and we hope it will be used as a springboard for Australasian clinical research into this area.

Entities:  

Year:  2010        PMID： 20179794      PMCID： PMC2826264     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN： 0159-8090


  7 in total

Review 1.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

2.  Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.

Authors:  A H Thomson; C E Staatz; C M Tobin; M Gall; A M Lovering
Journal:  J Antimicrob Chemother       Date:  2009-03-19       Impact factor: 5.790

3.  Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides.

Authors:  Jordi Rello; Jordi Sole-Violan; Marcio Sa-Borges; Jose Garnacho-Montero; Emma Muñoz; Gonzalo Sirgo; Montserrat Olona; Emili Diaz
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

4.  Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.

Authors:  M Wysocki; F Delatour; F Faurisson; A Rauss; Y Pean; B Misset; F Thomas; J F Timsit; T Similowski; H Mentec; L Mier; D Dreyfuss
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.

Authors:  Paul R Ingram; David C Lye; Paul A Tambyah; Wei P Goh; Vincent H Tam; Dale A Fisher
Journal:  J Antimicrob Chemother       Date:  2008-03-10       Impact factor: 5.790

Review 6.  Antimicrobial dosing considerations in obese adult patients.

Authors:  Manjunath P Pai; David T Bearden
Journal:  Pharmacotherapy       Date:  2007-08       Impact factor: 4.705

7.  Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Authors:  Thomas P Lodise; Ben Lomaestro; Jeffrey Graves; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191
  7 in total
  40 in total

1.  Electrochemical Aptamer-Based Sensors for Improved Therapeutic Drug Monitoring and High-Precision, Feedback-Controlled Drug Delivery.

Authors:  Philippe Dauphin-Ducharme; Kyungae Yang; Netzahualcóyotl Arroyo-Currás; Kyle L Ploense; Yameng Zhang; Julian Gerson; Martin Kurnik; Tod E Kippin; Milan N Stojanovic; Kevin W Plaxco
Journal:  ACS Sens       Date:  2019-10-15       Impact factor: 7.711

2.  Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.

Authors:  Terry E Jones; Hayley Vasileff; Cassie Hewton
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

3.  Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Maya Hites; Marjorie Beumier; Sabino Scolletta; Frédérique Jacobs
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

4.  Top Guns: The "Maverick" and "Goose" of Empiric Therapy.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-10-20       Impact factor: 2.150

5.  Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration.

Authors:  Xingang Li; Shusen Sun; Xi Ling; Kai Chen; Qiang Wang; Zhigang Zhao
Journal:  Eur J Clin Pharmacol       Date:  2017-08-29       Impact factor: 2.953

6.  Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.

Authors:  Xi-Wei Ji; Shuang-Min Ji; Xiao-Rong He; Xiao Zhu; Rong Chen; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2017-08-24       Impact factor: 6.150

7.  External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

Authors:  Wei Zhao; Florentia Kaguelidou; Valérie Biran; Daolun Zhang; Karel Allegaert; Edmund V Capparelli; Nick Holford; Toshimi Kimura; Yoke-Lin Lo; José-Esteban Peris; Alison Thomson; John N van den Anker; May Fakhoury; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

8.  Acute renal failure due to vancomycin toxicity in the setting of unmonitored vancomycin infusion.

Authors:  Shagufta Vora
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-10

9.  Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.

Authors:  Ren Zhang; Ming Chen; Tao-Tao Liu; Jie-Jiu Lu; Chun-le Lv
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

10.  Vancomycin-Associated Nephrotoxicity: The Obesity Factor.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Sara A Hennessy; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-09-01       Impact factor: 2.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.